Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
D Goncalves, M Mezidi, P Bastard… - Clinical & …, 2021 - Wiley Online Library
Objectives Impairment of type I interferon (IFN‐I) immunity has been reported in critically ill
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients.
D Goncalves, M Mezidi, P Bastard… - Clinical & …, 2021 - search.ebscohost.com
Objectives: Impairment of type I interferon (IFN‐I) immunity has been reported in critically ill
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
[PDF][PDF] Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients
D Goncalves, M Mezidi, P Bastard, M Perret, K Saker… - scienceopen.com
Objectives. Impairment of type I interferon (IFN-I) immunity has been reported in critically ill
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
[HTML][HTML] Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
D Goncalves, M Mezidi, P Bastard… - Clinical & …, 2021 - ncbi.nlm.nih.gov
Objectives Impairment of type I interferon (IFN‐I) immunity has been reported in critically ill
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
D Goncalves, M Mezidi, P Bastard, M Perret… - Clinical & Translational …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objectives</jats: title>< jats: p>
Impairment of type I interferon (IFN‐I) immunity has been reported in critically ill COVID‐19 …
Impairment of type I interferon (IFN‐I) immunity has been reported in critically ill COVID‐19 …
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients
D Goncalves, M Mezidi, P Bastard… - Clinical & …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives Impairment of type I interferon (IFN-I) immunity has been reported in critically ill
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
Antibodies against type-I Interferon: detection and association with severe clinical outcome in COVID-19 patients
D Goncalves, M Mezidi, P Bastard, M Perret, K Saker… - 2021 - pesquisa.bvsalud.org
ObjectivesImpairment of type I interferon (IFN-I) immunity has been reported in critically-ill
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
D Goncalves, M Mezidi, P Bastard… - Clinical & …, 2021 - search.proquest.com
Objectives Impairment of type I interferon (IFN‐I) immunity has been reported in critically ill
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
D Goncalves, M Mezidi, P Bastard, M Perret… - Clinical and …, 2021 - hal.science
Objectives: Impairment of type I interferon (IFN-I) immunity has been reported in critically ill
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients.
D Goncalves, M Mezidi, P Bastard, M Perret… - Clinical & …, 2021 - europepmc.org
Objectives Impairment of type I interferon (IFN-I) immunity has been reported in critically ill
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …
COVID-19 patients. This defect can be explained in a subset of patients by the presence of …